干货:论文写作拖延症,这病该怎么治?

2015-10-30 小米 解螺旋

前不久,一篇施一公一晚上通宵如何写出Nature、Cell论文的文章在网络上传得很厉害,同是科研工作者,是不是很羡慕呢?发Nature、Cell不是人人都能做到的,但是快速写论文这个事,还是可以尝试的。 对于大多数人来说,写论文实在是个头疼事,本来计划好什么时候开始写,什么时候完成,可就是动不了笔,今天拖明天,明天拖后天,日子一天天过去,却发现一个字都没有动,进度就这么给耽误了,想想对自己也

前不久,一篇施一公一晚上通宵如何写出Nature、Cell论文的文章在网络上传得很厉害,同是科研工作者,是不是很羡慕呢?发Nature、Cell不是人人都能做到的,但是快速写论文这个事,还是可以尝试的。

对于大多数人来说,写论文实在是个头疼事,本来计划好什么时候开始写,什么时候完成,可就是动不了笔,今天拖明天,明天拖后天,日子一天天过去,却发现一个字都没有动,进度就这么给耽误了,想想对自己也是蛮生气的。学术写作停止不前,这是病,得治!

让学术写作停滞不前的往往不是学术问题,而是不良的写作习惯。而这习惯来自于思想顽疾,那就是纠结于一个问题:拿不出一整天或一整周的时间专门用来写作,很难写出很好的作品,既然写不出好的作品,干嘛要去写?归结一点就是:怕写得不够好而迟迟不肯动笔。

治病救人,对症下药,思想上的问题自然从思想上去解决,下面小编就开个几个处方,一一照做,基本上就没什么问题了。

处方一:不等万事具备,硬起头皮写

不要准备好了才动笔,你永远都不会觉得自己准备好了。你试试假如明天就答辩,你肯定抓起笔来就写,哪里顾得上什么准备。“准备好了”不过是拖延的借口而已。不要等到把文章一点一滴都想清楚了才下笔。不管想到什么先写下来,想到哪儿写到哪儿,写就是了。往往写着写着思路就理清了。

有些人每天看大量的文献、做很多的实验,以为这样就能“准备好”--这种人我们称之为“文献派”和“实验派”。可到头来往往是看得越多、做得越熟,就越是搞不清自己要写些什么,计划动笔的日期一拖再拖。所以什么文献、实验统统停掉,拿起笔来开始写字。没什么好准备的,老老实实写吧。

这一点,小编是深有体会。当初小编写毕业论文时也是深受写作拖延症之苦,临近毕业事情一大堆,可老想着论文还没完成,别的事情都没有心思去做,可论文总是难以下笔。这种煎熬实在是太难受了,终于有天不管三七二十一,不管对错好坏,把想到的都写出来,总算是开了个头,倒真是应了那句:“万事开头难”,写着写着竟然也有了些感觉。

处方二:别总指望着整块时间,学会游击写作

千万不要寄期望于有大段的空余时间供你慢慢写--整块儿的专门时间本来就少,况且真到了那个时候你也不一定能静下心来写好。但实践证明:十几分钟不但能写,还能写出高水平的东西。

很多人认为十几分钟的时间根本写不出什么东西来。研究发现,平均来说,比起花大段时间著述的学者,每天写上半个小时的人发表的论文更多。

要学会利用零碎时间,排队的时候、等车的时候、课间一二十分钟,都可以用来写。一周五天、天天写上45分钟,效果自然就出来了。想增加文章发表数量的,每天最好能够保证45到90分钟的写作时间。这被称之为游击写作。一般说来,早晨是游击写作的最佳时间。这时没什么外界干扰,可以全神贯注地写论文。当然化零为整必须定时保量,一周只游击45分钟是没用的。

处方三:摒弃完美主义思想,不怕写得烂

写文章要想清楚了才下笔,这个提法看上去很有道理,其实,在实际写作过程中根本不是那么回事儿。往往论文大致框架都想好了,可坐下来写的时候才发现根本不是想的那样--不是这里逻辑不对就是那里缺少数据,一会儿链接也打不开了。那时才发现自己当初想得太简单,根本没有考虑周全。而写作恰恰是理清思路的好帮手。写作本身就是一个思考的过程,在写的过程中,你的想法不断地被修正,所以你“不要停、只管写”的原因,也不管你一开始写得多烂,不要停,继续写。

综上,摆脱论文写作拖延症,就别想太多,只管写,不停地写就对了。当然,还需要配合以正确的写作技巧,这就要靠平时多多积累。掌握了这些,在短时间内写出高水平的学术论文也就不是什么难事了。


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1956959, encodeId=bd8a195695900, content=<a href='/topic/show?id=6a6f5622517' target=_blank style='color:#2F92EE;'>#拖延症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56225, encryptionId=6a6f5622517, topicName=拖延症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Tue Jun 28 07:48:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42128, encodeId=d45a4212883, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/29/bf4f15fc3880b83286648eb0481da33b.jpg, createdBy=0d741615323, createdName=pharmxing, createdTime=Sun Nov 01 12:13:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279567, encodeId=7a0712e95676c, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sun Nov 01 02:48:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42007, encodeId=54b84200e9a, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Fri Oct 30 21:57:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41958, encodeId=a1a34195864, content=好好治治, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Fri Oct 30 13:14:00 CST 2015, time=2015-10-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1956959, encodeId=bd8a195695900, content=<a href='/topic/show?id=6a6f5622517' target=_blank style='color:#2F92EE;'>#拖延症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56225, encryptionId=6a6f5622517, topicName=拖延症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Tue Jun 28 07:48:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42128, encodeId=d45a4212883, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/29/bf4f15fc3880b83286648eb0481da33b.jpg, createdBy=0d741615323, createdName=pharmxing, createdTime=Sun Nov 01 12:13:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279567, encodeId=7a0712e95676c, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sun Nov 01 02:48:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42007, encodeId=54b84200e9a, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Fri Oct 30 21:57:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41958, encodeId=a1a34195864, content=好好治治, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Fri Oct 30 13:14:00 CST 2015, time=2015-10-30, status=1, ipAttribution=)]
    2015-11-01 pharmxing

    有道理

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1956959, encodeId=bd8a195695900, content=<a href='/topic/show?id=6a6f5622517' target=_blank style='color:#2F92EE;'>#拖延症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56225, encryptionId=6a6f5622517, topicName=拖延症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Tue Jun 28 07:48:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42128, encodeId=d45a4212883, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/29/bf4f15fc3880b83286648eb0481da33b.jpg, createdBy=0d741615323, createdName=pharmxing, createdTime=Sun Nov 01 12:13:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279567, encodeId=7a0712e95676c, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sun Nov 01 02:48:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42007, encodeId=54b84200e9a, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Fri Oct 30 21:57:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41958, encodeId=a1a34195864, content=好好治治, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Fri Oct 30 13:14:00 CST 2015, time=2015-10-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1956959, encodeId=bd8a195695900, content=<a href='/topic/show?id=6a6f5622517' target=_blank style='color:#2F92EE;'>#拖延症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56225, encryptionId=6a6f5622517, topicName=拖延症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Tue Jun 28 07:48:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42128, encodeId=d45a4212883, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/29/bf4f15fc3880b83286648eb0481da33b.jpg, createdBy=0d741615323, createdName=pharmxing, createdTime=Sun Nov 01 12:13:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279567, encodeId=7a0712e95676c, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sun Nov 01 02:48:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42007, encodeId=54b84200e9a, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Fri Oct 30 21:57:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41958, encodeId=a1a34195864, content=好好治治, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Fri Oct 30 13:14:00 CST 2015, time=2015-10-30, status=1, ipAttribution=)]
    2015-10-30 梦想天空

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1956959, encodeId=bd8a195695900, content=<a href='/topic/show?id=6a6f5622517' target=_blank style='color:#2F92EE;'>#拖延症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56225, encryptionId=6a6f5622517, topicName=拖延症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Tue Jun 28 07:48:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42128, encodeId=d45a4212883, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/29/bf4f15fc3880b83286648eb0481da33b.jpg, createdBy=0d741615323, createdName=pharmxing, createdTime=Sun Nov 01 12:13:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279567, encodeId=7a0712e95676c, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sun Nov 01 02:48:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42007, encodeId=54b84200e9a, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Fri Oct 30 21:57:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41958, encodeId=a1a34195864, content=好好治治, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Fri Oct 30 13:14:00 CST 2015, time=2015-10-30, status=1, ipAttribution=)]
    2015-10-30 三三五五

    好好治治

    0

相关资讯

CSCO 2015:JCO审稿流程与论文写作

The Journal of Clinical Oncology(JCO,临床肿瘤学杂志)为读者提供可信,权威而重大的临床肿瘤学研究资讯,有印刷版和电子版两种。在本届CSCO年会论文撰写与国际期刊投稿专场上,来自香港中文大学威尔斯医院,JCO副主编莫树锦教授详细阐述了JCO如何审稿及论文写作方面的知识。以下为演讲PPT整理,供参考借鉴。为何会被拒稿?投稿JCO的论文有87%会被拒,原因通常是论文思

科研思维与论文写作之“5C”法则

科学研究是开拓求新和严谨求实的有机结合,在科研设计和论文撰写的过程中需要遵循一些基本原则。本文创新性地提出科研思维和论文写作的“5C”法则,包括评判性(critical)、一致性(consistent)、简洁性(concise)、清晰性(clear)和完整性(complete),以期为年轻学者的科研训练和研究生教育提供参考。 科学研究实践可以用胡适先生提出的“大胆假设,小心求证”进行

你请统计学家来做尸体解剖吗?

论文的死法有上千种,但有一种死法你不能喊冤。我们先来看一个故事:2006年,在国际期刊Nature Medicine上发表一篇文章——Using the NCL60 to Predict Sensitivity(Potti et al(2006), Nature Medicine, 12:1294-1300.)。这篇文章的结论主要是说采用NCL60细胞系的基因芯片数据可以确定化疗药物反应特征,以预

EndNote 7.0 中文使用教程

简 介Endnote 由Thomson Corporation下属的Thomson ResearchSoft 开发。 Thomson ResearchSoft是以学术信息市场化和开发学术软件为宗旨的子公司。Thomson Corporation总部位于美国康涅狄格州的Stamford。Endnote是文献管理和论文写作的利器!Endnote的功能一、在线搜索文献:直接从网络搜索相关文献并导

如何投稿英文期刊,来自编辑的十条建议

本文基于投稿中的常见问题,以编辑视角给出了十条宝贵的建议。以下这些窍门虽然不能保证你的稿件一定被采用,但至少能让你的投稿对编辑和审稿人更有吸引力。1.了解想要投稿的刊物每一份杂志都有自己的宗旨和覆盖领域,这样的信息在它们的网站上都有介绍。近年来,新刊物如雨后春笋一般冒出来,电子投稿又逐渐成为主流,作者们很容易忽视不同杂志的投稿指南,不进行有针对性的修改。说实话,再没什么比这样的事更令编辑心烦了,了

CSCO 2015:《柳叶刀》编辑谈中国作者投稿常见问题

《柳叶刀》是由外科医生Thomas Wakley创办的综合性的临床医学期刊,在目前四大医学期刊中是唯一独立的期刊。每年接收自投稿数量大约10,000篇,来自中国的投稿已超过1000篇。Lancet一般不接收基础研究类文章。本文根据CSCO年会论文撰写与国际期刊投稿专场上Lancet亚洲编辑王辉演讲PPT整理。审稿原则:• 能否改变临床实践和卫生制度  • 是否受众层面广(专业性太强的稿件